Navamedic

Contact
navamedic.com
+4767112540

Navamedic ASA

Fornebuveien 42-44, P.O. Box 107
1327 Lysaker
Norway
+4767112540
navamedic.com
Contact
Profile News
Contact

About Navamedic

Navamedic ASA is a Norwegian speciality pharmaceutical company focusing on the development and production of glucosamine HCl based medicines. Glucosamine is a generic active ingredient which relieves pain and improves function in patients with mild to moderate osteoarthritis in the knee. Glucosamine has a favourable safety profile. Osteoarthritis is a chronic disease which affects a large and growing share of the world’s population.

Read more about Navamedic
Facts about Navamedic
  • Focus : Manufacturer
  • Industry : Pharma

News about Navamedic

Navamedic

23-Sep-2009 | people

New CFO in Navamedic ASA

Torbjörn Sannerstedt has been appointed as the new CFO of Navamedic. Before Navamedic, Torbjörn Sannerstedt held the CFO position at AcadeMedia Company. ...

Read news
Navamedic

07-May-2009 | people

New CEO in Navamedic ASA

Olof Milveden is appointed new CEO of Navamedic ASA. Olof Milveden has 27 years of experience from the pharma/health care industry. His last position has ...

Read news
Navamedic

12-Nov-2008 | business & finance

Navamedic concentrates key resources on the development of its Vitaflo business

Company will initiate a process to move main head office functions to Gothenburg

Read news
Navamedic

25-Apr-2008 | business & finance

Navamedic sells chitin operation - Focus on core strategy

Navamedic sells ChitiNor AS to Seagarden AS for NOK 2.3 million in shares. The decision is in line with the company's strategy to move from a glucosamine ...

Read news
Navamedic

24-Oct-2007 | business & finance

Vitaflo signs new in-licensing agreement for Nordic countries

Navamedic's fully owned subsidiary Vitaflo Scandinavia AB has signed a new in-licensing agreement with OrphaSwiss GmbH for marketing of two products in ...

Read news
Navamedic

09-Oct-2007 | business & finance

Navamedic ASA completes the acquisition of Vitaflo Scandinavia AB

On 4 October, Navamedic ASA completed the acquisition of 100% of the shares in the Swedish pharmaceutical company Vitaflo Scandinavia AB, and takes the ...

Read news
Navamedic

23-Aug-2007 | business & finance

Navamedic ASA acquires Vitaflo Scandinavia AB and initiates a new strategic phase

Navamedic ASA entered into an agreement with POA Consulting Scandinavia AB concerning the acquisition of the Swedish speciality pharmaceutical company ...

Read news
Navamedic

02-May-2007 | business & finance

Final agreement between Navamedic and Grünenthal for Glucodmed/Flexove marketing in Mexico

Navamedic ASA and Grünenthal GmbH have signed the final agreement for marketing and distribution of Glucomed/Flexove in Mexico. On the 22 February 2007, ...

Read news
Show more news about Navamedic

Here you will find Navamedic ASA

Last viewed contents

Segond_fracture

Go to page